A 1995 clip from ABC television's flagship magazine program featuring Dr. D'Amato discussing the lab's early work on macular degeneration as well Edmund Aleksandrovich, an AMD sufferer and late founder of the Macular Degeneration Foundation.
From Thalidomide to Pomalyst: Better living through chemistry
Posted on April 2, 2013 by David Altman BCH Technology office
Posted in Innovation, People, Therapeutics
In times past, a pharmaceutical chemist’s main focus was to synthesize novel molecules to treat diseases. Today, an increasingly popular alternative is to re-engineer an existing drug—and continually improve it even after FDA approval. That’s how Robert D’Amato, MD, PhD, developed Pomalyst®, recently approved to treat multiple myeloma and the most potent analog to date of...